1 / 7

Stem Cell Therapy Market

Stem Cell Therapy Market

IRFAN13
Download Presentation

Stem Cell Therapy Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. stem cell therapy market Research Report Analysis and Forecasts to 2027 © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  2. Global stem cell therapy market • The stem cell therapy market is anticipated to expand substantially by 2027 on account of ongoing R&D in the field and recent advancements in regenerative medicines across key regions. • Stem cells possess the ability to differentiate into a variety of different cell types. The key characteristics of stem cells include their ability to develop into a specific adult cell type and constant self-renewal. Stem cells are extensively used in tissue repair and regeneration owing to their ability to build every tissue in the human body. • To access a sample copy or view the market report in detail along with the table of • contents, please click the link below:https://www.gminsights.com/request-sample/detail/3331 • Growing awareness and capabilities of healthcare institutions across developing economies, particularly regarding the benefits of stem cell therapy has fueled market expansion in recent years. • Several industry players have been engaging in profitable strategies to tap into emerging trends in the market, which has favorably impacted the overall business landscape. For instance, in July 2021, Astellas Pharma Inc., a global pharmaceutical company, announced a collaboration with Minovia Therapeutics, Ltd., a leading biotechnology company. © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  3. Continue:- • According to the terms of the deal, both firms have agreed to combine expertise to conduct R&D as well as the commercialization of novel cell therapy programs for diseases caused by mitochondrial dysfunction. • In another instance, in May 2021, FUJIFILM Cellular Dynamics, Inc., a prominent manufacturer of human cells for regenerative medicine applications, entered into an alliance with BlueRock Therapeutics LLC, a major biopharmaceutical company, and Opsis Therapeutics, LLC, a joint venture of FUJIFILM Cellular Dynamics and co-founder David Gamm. The alliance is intended to enable collaborative R&D efforts towards the development of cell therapies for eye diseases. • Browse key industry insights spread across 110 pages with 90 market data tables & 14 figures & charts from the report, “Stem Cell Therapy Market Size By Type (Allogenic Stem Cell Therapy, Autologous Stem Cell Therapy), By Therapeutic Area (Oncology, Orthopedic, Cardiovascular, Neurology), End-use (Hospitals, Clinics), COVID-19 Impact Analysis, Regional Outlook, Technology Potential, Competitive Market Share & Forecast, 2021 – 2027” in detail along with the table of contents:https://www.gminsights.com/industry-analysis/stem-cell-therapy-market © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  4. 360° Industry Analysis • The stem cell therapy market has been categorized on the basis of type, end-use, therapeutic area, and regions. With respect to type, the market has further been divided into autologous and allogenic. The autologous sub-segment is expected to attain a valuation of around USD 11.0 billion by the end of 2027. • In terms of therapeutic area, the stem cell therapy market has been segmented into neurology, oncology, cardiovascular, orthopedic, and others. In 2020, the orthopedic sub-segment accounted for revenues worth nearly USD 850.5 million and is set to grow at a sturdy pace over the assessment period. • From the end-use perspective, the market has been bifurcated into clinics, hospitals, and others. The stem cell therapy market from the clinics sub-segment is speculated to amass significant gains by 2027, expanding at a pace of approximately 10.8% CAGR through the analysis timeline. • On the regional front, the Latin America stem cell therapy market held a market share of almost 7.4% in 2020 and is likely to showcase optimistic growth over the forecast timeframe. • The Middle East & Africa stem cell therapy market is poised to gain notable traction by 2027, growing at an impressive CAGR of over 10.5% through the study timeline. © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  5. Partial Table of Contents (ToC) of the report: • Chapter 1   Methodology • 1.1    Market definition • 1.2    Base estimates & working • 1.2.1    North America • 1.2.2    Europe • 1.2.3    Asia pacific • 1.2.4    Latin America • 1.2.5    Middle East & Africa • 1.3    Forecast parameters • 1.4    Data validation • 1.5    Data sources • 1.5.1    Secondary • 1.5.1.1    Paid sources • Chapter 2   Executive Summary • 2.1    Stem cell therapy industry 3600 synopsis, 2016 - 2027 • 2.1.1    Business trends • 2.1.2    Type trends • 2.1.3    Therapeutic area trends © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  6. Market Players: • Astellas Pharma Inc,  • Novadip Biosciences,  • MEDIPOST,  • Fujifilm Cellular Dynamics, • Browse complete table of content of this report@ https://www.gminsights.com/industry-analysis/stem-cell-therapy-market# © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  7. Stay In Touch You can visit us at: www.gminsights.com Thank You…! © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

More Related